Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. - Wikidata - awgldk - TriplyDB

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

http://www.wikidata.org/entity/Q35874779

about

Clostridium difficile associated diarrhoea: diagnosis and treatment.Bench-to-bedside review: Clostridium difficile colitis Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections Recent Advances in the Diagnosis and Treatment of Clostridium Difficile Infection Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic review Clostridium difficile Infection in Children: Current State and Unanswered Questions Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review Recent changes in Clostridium difficile infection Antimicrobial safety: focus on fluoroquinolones Molecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in Thailand Trends in Clostridium difficile Disease: Epidemiology and Intervention Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions The changing epidemiology of Clostridium difficile infections Interspecies Interactions between Clostridium difficile and Candida albicans Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case report Automated surveillance of Clostridium difficile infections using BioSense.Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Clostridium difficile infection: Updates in management.Clostridium difficile infection: New insights into therapeutic options.The microbiota and immune response during Clostridium difficile infection.Glutamine and alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-a-induced intestinal epithelial cell damage Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains.Surveillance of prescription drug-related mortality using death certificate data.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.Clostridium difficile ribotype 027, toxinotype III, the Netherlands.Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.Clinical review of the management of fulminant clostridium difficile infection.Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review Prevalence of diverticulosis in recurrent Clostridium difficile infection Clostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Multilocus sequence typing of Clostridium difficile Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.Analysis of ultra low genome conservation in Clostridium difficile.

P2860

Q24531456-19403FC4-12CB-458D-AEEB-3A72155370CE Q24644191-C13B6BF9-2D09-4F8E-A286-B1F488EA4F35 Q26752760-B6536390-B85D-4F18-8764-8B283458A075 Q26766112-6E15DDB1-0644-4C05-A488-E0275346281F Q26767079-4D5BE88E-9802-44B4-93DB-AA28D5654A43 Q26800020-5246E137-9E7B-4EB6-BF19-E8ED96FD99F5 Q26827693-7A51ADFD-DB56-4A40-B306-6D81682A2830 Q27016320-C4127D5A-F1EB-448F-BFF8-C3C2DCE8358C Q27021390-01560D9B-F33F-40D9-A598-D4E7193B9890 Q27022537-7535F9F1-BBC0-4DEC-B126-BCAD4E2F8ADC Q28255152-68B2CA7B-CF32-4F31-B150-212229C3738A Q28547441-76E7EF4F-4CD7-472A-97D7-BC8E91C638A3 Q28655729-CE7F3A28-7A60-4550-810C-E5F6EC9AA1C5 Q28732437-984F95DA-5999-4521-8FB2-FDDE0CC55232 Q28743438-F33BA70F-B342-47D6-A972-6737C117B78E Q28750385-0AD3792D-C03A-4E00-A404-2A35EDA0F322 Q28821706-E667754B-3299-4A72-8529-0AC69AAFA196 Q28828482-683D8E94-85D1-4BD0-B5FC-74F25A825D15 Q30226865-EBAAFCEA-96B4-457F-9837-8C3510AF5E97 Q30229124-F4BCBFDC-C8F6-4360-BB4E-909E21855E8F Q30235905-EC7F7ED6-A543-4BED-ABE6-648070BC244C Q30239988-D604318A-2716-4808-B5CE-AD089156C337 Q30252154-BD87EB7B-9DC8-4D87-A2A1-C19BE26E0C2E Q30276756-E7EDD769-54B1-4A42-AA96-F75774B7C2F2 Q30421944-7281E0CD-C6A0-442B-BEA4-4DBA214290C8 Q30427422-7782C50A-EA95-43EA-808C-9453076702CD Q30434665-5395C2EB-80EB-4002-A6CB-70B50177C2C6 Q30475404-FCB2ADD5-172D-4A66-88D1-62750C0CFB96 Q31114133-1BBD4474-00B8-4CA2-8670-27A3F479CA7A Q33214954-14E97BE4-43F6-498E-8AEC-B8A51B580A8E Q33243642-10E858ED-602A-4A64-8B76-711A97A50868 Q33276804-F4A9042F-2893-4952-883B-36374D585FBC Q33375824-C8D4BB2E-059B-4126-BAA2-979830CBB958 Q33475206-EDB7331C-2790-4D44-A633-28F19F480F5E Q33518583-891D1DF4-B435-4F45-8371-3D187221F3C0 Q33596510-40D859C1-00B8-44B9-9D8C-C2555905D95D Q33603104-3B4BE1F9-62DD-4DDD-9928-927608FCA17A Q33704701-FB4444E4-366A-47C3-A110-7D74CDEBCF1F Q33729925-16E871CC-638D-4FC8-BE6F-066BEDBDBF1E Q33775602-6D87F543-60A5-432D-BBAE-8FA0912BD846

P2860

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

http://www.wikidata.org/entity/Q35874779

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Clostridium difficile-associat ...... g pattern of disease severity.

@ast

Clostridium difficile-associat ...... g pattern of disease severity.

@en

type

label

Clostridium difficile-associat ...... g pattern of disease severity.

@ast

Clostridium difficile-associat ...... g pattern of disease severity.

@en

prefLabel

Clostridium difficile-associat ...... g pattern of disease severity.

@ast

Clostridium difficile-associat ...... g pattern of disease severity.

@en

P1433

Q35874779-BB04B57D-86A2-4E4C-956C-D235DD4B4FBD

P1476

Q35874779-9E3437E2-1050-47EC-A1BF-62346E96B321

P2093

Q35874779-0D38BD60-320A-49E7-AAC3-F794BF24F634

Q35874779-3B83C302-469D-40D3-ADCE-DAA3BAEE5379

Q35874779-493188CB-9F10-4220-85D9-F22B2F09902C

Q35874779-991C0380-52D2-490C-B6E2-11AE5E278386

Q35874779-A877A324-E6EC-4C87-8565-0110CA08782B

Q35874779-A8C1CB90-8C1B-4EE5-89C5-66D50E63C85B

Q35874779-D31588EB-848C-4CE9-9F40-9ED76D7A28FD

P2860

Q35874779-06AAF249-DDB7-4A3E-BD51-B44F483CEECE

Q35874779-0EF2A2EA-C8B6-4BB0-BA01-75C26EE77A8A

Q35874779-1D1F4240-D198-4211-9380-4996A3BF5444

Q35874779-1D91D7BC-7106-415C-A05E-7E78C6957419

Q35874779-42E0E966-D94B-48C2-AE46-2A2B8EBF0BF7

Q35874779-5C5CE8EF-70CF-489A-9F21-61714C703A93

Q35874779-5F8705F6-9D22-4A1F-9A9B-E4C1FB9B24BD

Q35874779-92BF8452-76A4-4F3A-A905-CA30F0B080BD

Q35874779-93C26F05-3A55-408E-8F4B-82A0CC6A6077

Q35874779-945BDBD8-0505-40B6-89F6-1BB90B82FEF9

P304

Q35874779-61340320-7D1D-4462-98EA-DE8ED31868B4

P31

Q35874779-418BED6F-6932-40E7-A92E-575721C22F57

P356

Q35874779-D94A79D6-820E-4DFD-A358-4F774EBFD33D

P407

Q35874779-449BC448-EFCB-40DA-BD54-D7B0796CFEA9

P433

Q35874779-21F373F2-2250-4485-A755-557D2D3474F7

P478

Q35874779-AEA8913A-714C-41F2-947E-647E399F55B3

P50

Q35874779-704E89CD-535F-4B4B-82FD-BEFAA830CB76

P577

Q35874779-98F4DF06-893F-49D9-8F35-09386F3FF3D7

P5875

Q35874779-FE89CF22-5119-4F9A-B5CA-45530D3E2428

P698

Q35874779-96EF0A49-BDCB-49FA-B4F1-7CBE44658F6D

P921

Q35874779-06544F84-3DC9-4410-8481-B3000A88FAC1

Q35874779-95659EEE-807B-4E35-AACA-B49E024BDE65

P932

Q35874779-3BA85774-E2ED-463D-8F31-FD159FABC6B1

P356

P1433

Canadian Medical Association Journal

P1476

Clostridium difficile-associat ...... g pattern of disease severity.

@en

P2093

Annick Pelletier

http://www.w3.org/2001/XMLSchema#string

Daniel Chouinard

http://www.w3.org/2001/XMLSchema#string

Jacques Pépin

http://www.w3.org/2001/XMLSchema#string

Karine Forget

http://www.w3.org/2001/XMLSchema#string

Karine Pépin

http://www.w3.org/2001/XMLSchema#string

Marie-Eve Alary

http://www.w3.org/2001/XMLSchema#string

Philippe Villemure

http://www.w3.org/2001/XMLSchema#string

P2860

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

Clostridium difficile: clinical considerations.

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.

Risk factors for Clostridium difficile infection.

Clinical practice. Antibiotic-associated diarrhea.

Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital.

Clostridium difficile infection: responses, relapses and re-infections.

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

P304

466-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.1041104

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Louis Valiquette

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8374244

http://www.w3.org/2001/XMLSchema#string

P698

15337727

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

Afọ ọsịsa

P932

514643

http://www.w3.org/2001/XMLSchema#string